92 related articles for article (PubMed ID: 16387359)
21. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
Goh HG; Hwang JY; Kim SH; Lee YH; Kim YL; Kim DW
Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
Amin HM; Hoshino K; Yang H; Lin Q; Lai R; Garcia-Manero G
J Pathol; 2007 Aug; 212(4):402-10. PubMed ID: 17503411
[TBL] [Abstract][Full Text] [Related]
24. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells.
de Lange P; Segeren CM; Koper JW; Wiemer E; Sonneveld P; Brinkmann AO; White A; Brogan IJ; de Jong FH; Lamberts SW
Cancer Res; 2001 May; 61(10):3937-41. PubMed ID: 11358809
[TBL] [Abstract][Full Text] [Related]
25. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
Ruan GR; Qin YZ; Chen SS; Li JL; Ma X; Chang Y; Wang YZ; Fu JY; Liu YR
Leuk Res; 2006 Sep; 30(9):1159-65. PubMed ID: 16507320
[TBL] [Abstract][Full Text] [Related]
26. Analysis of copy number variations of BS69 in multiple types of hematological malignancies.
Yang H; Zhang C; Zhao X; Wu Q; Fu X; Yu B; Shao Y; Guan M; Zhang W; Wan J; Huang X
Ann Hematol; 2010 Oct; 89(10):959-64. PubMed ID: 20425112
[TBL] [Abstract][Full Text] [Related]
27. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.
Burmeister T; Reinhardt R
Leuk Res; 2008 Apr; 32(4):579-85. PubMed ID: 17928051
[TBL] [Abstract][Full Text] [Related]
28. HOXA9 gene expression in the chronic myeloid leukemia progression.
Tedeschi FA; Zalazar FE
Leuk Res; 2006 Nov; 30(11):1453-6. PubMed ID: 16630659
[TBL] [Abstract][Full Text] [Related]
29. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
30. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
31. [RT-PCR use for the diagnostic of chronic myeloid leukaemia].
Menif S; El Borgi W; Jeddi R; Belakhal R; Elloumi M; Laatiri A; Meddeb B; Dellagi K
Arch Inst Pasteur Tunis; 2006; 83(1-4):35-9. PubMed ID: 19388595
[TBL] [Abstract][Full Text] [Related]
32. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.
Spinello I; Quaranta MT; Pasquini L; Pelosi E; Petrucci E; Pagliuca A; Castelli G; Mariani G; Diverio D; Foà R; Testa U; Labbaye C
Oncogene; 2009 Jun; 28(23):2276-88. PubMed ID: 19421145
[TBL] [Abstract][Full Text] [Related]
33. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
34. Hematological and molecular response evaluation of CML patients on imatinib.
Gupta A; Prasad K
J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
[TBL] [Abstract][Full Text] [Related]
35. Expression and significance of IL-18 in the bone marrow of patients with hematological diseases.
Zhang B; Rao Q; Zheng G; Cao Z; Ma X; Li G; Lin Y; Geng Y; Wu K
Chin Med J (Engl); 2003 Feb; 116(2):218-21. PubMed ID: 12775234
[TBL] [Abstract][Full Text] [Related]
36. The Janus Kinase 2 (JAK2) V617F mutation in hematological malignancies in México.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ; Navarro-Vázquez M; González-Carrillo ML
Rev Invest Clin; 2006; 58(5):458-61. PubMed ID: 17408106
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy.
Jilani I; Kantarjian H; Gorre M; Cortes J; Ottmann O; Bhalla K; Giles FJ; Albitar M
Leuk Res; 2008 Apr; 32(4):643-9. PubMed ID: 17900686
[TBL] [Abstract][Full Text] [Related]
38. The Kit ligand/c-Kit receptor system in goat ovaries: gene expression and protein localization.
Silva JR; van den Hurk R; van Tol HT; Roelen BA; Figueiredo JR
Zygote; 2006 Nov; 14(4):317-28. PubMed ID: 17266790
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells.
Chen JY; Wang MC; Hung WC
Leuk Res; 2009 Nov; 33(11):1520-4. PubMed ID: 19329185
[TBL] [Abstract][Full Text] [Related]
40. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]